Streetbeat News

HYPMY

Hypera S.A.

Industry

Medicinal and Botanical Manufacturing

Open

3.52

Mkt cap

2.2B

Volume

228

High

3.52

P/E Ratio

7.65

52-wk high

7.90

Low

3.52

Div yield

0.01

52-wk low

3.49

Trading of Hypera's shares was halted in Sao Paulo. This may affect the US-listed ADR, HYPMY, as investors react to the news.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 4:46 pm

EMS has proposed a merger with Hypera, which would create Brazil's largest pharmaceutical company with a 17% market share. This merger could significantly impact the pharmaceutical landscape in Brazil.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 4:43 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.